Cleveland Clinic Innovations

Cleveland Clinic Innovations will be attending Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa from October 7-9 in Phoenix, AZ! ?? Heather Callahan, PhD, JD, EMBA, General Manager of Business Development & Licensing, will be representing us for this great opportunity to join the conversation about the latest in cutting-edge cell therapy technology, gene therapies, and more. To connect with Heather and check out our highlighted technologies, please look for us in the portal under "Cleveland Clinic Innovations". https://hubs.li/Q02PTf7y0 #CGMesa24 #Innovation #ClevelandClinic #medtech #ClevelandClinicInnovations #RegenerativeMedicine #CellTherapy #GeneTherapy #ClinicalResearch

??Subscribe today: https://hubs.li/Q02PSxxM0 ??Sign up for Cleveland Clinic Innovations' quarterly newsletter, Innovations Insights, to receive announcements, portfolio company news, technology spotlights, ways to partner with us, webinar updates, and more! Discover cutting-edge technologies and advancements shaping the future of healthcare. Don’t miss out – be informed, be inspired! #clevelandclinic #ClevelandClinicInnovations #newsletter #innovation #healthcareinnovation

Centerline Biomedical, a Cleveland Clinic Innovations portfolio company, is making waves with its Intra-Operative Positioning System (IOPS) and was recently covered in Crain's Cleveland Business. This groundbreaking technology aims to replace the current reliance on fluoroscopy in orthopedic procedures, reducing radiation exposure for surgeons and improving safety. The recently FDA-cleared IOPS Viewpoint Catheter offers real-time visualization of endovascular tools using electromagnetic tracking, a significant step forward from traditional fluoroscopy systems. Developed by former Cleveland Clinic researcher Vikash Goel and the late Dr. Roy Greenberg, the system includes a portable cart, electromagnetic field generator, and sensor-integrated catheters and guidewires. It promises to enhance operating room efficiency and safety by providing clearer, real-time navigation feedback. With a new CFO on board and a successful $33 million Series B funding round in 2022, Centerline Biomedical is set to continue advancing its innovative technology and improving clinician safety. Discover more about how Centerline Biomedical is changing the game in endovascular intervention: https://hubs.li/Q02PGPj_0 #MedTech #Innovation #Healthcare #Endovascular #RadiationSafety #ClevelandClinic #CenterlineBiomedical

Innovations Profile Alert! ?? Meet Mutua Mattu, PhD, our talented Innovations Patent Agent at Cleveland Clinic Innovations! In our latest profile feature, Mutua shares his inspiring journey from Kenya to Cleveland, reflecting on his unique path to joining our team and what innovation means to him. ???? From pursuing a chemistry PhD in Ohio to transitioning from a Principal Scientist to a Patent Agent, Mutua's career is a testament to the power of adaptability and continuous learning. His work at Cleveland Clinic Innovations focuses on refining our patent strategies, overseeing external legal partners, and creating an intellectual property (IP) playbook to streamline and enhance our innovation processes. He’s shaping the patent agent role to align with our goals, enhancing patent application quality and IP management while fostering collaboration. Mutua encourages aspiring inventors to embrace the process, seek guidance, and leverage collaboration to overcome challenges and drive innovation. Learn more about Mutua’s journey and his impact on our Innovations team in the full profile. His story exemplifies the spirit of innovation that drives Cleveland Clinic forward! ?? ?? https://hubs.ly/Q02PtV8g0 #HealthInnovation #DigitalHealth #ClevelandClinic #ClevelandClinicInnovations #Innovations #MeetTheTeam

??Did you know that September is Prostate Cancer Awareness Month? Cleveland Clinic Innovations portfolio company, Cleveland Diagnostics, Inc., is running its second annual prostate-specific antigen (PSA) campaign “A PSA on PSA” to raise awareness and education for prostate cancer screening tests. The campaign provides a comprehensive fact sheet with vital information on PSA tests, essential statistics, prevention tips, and crucial questions to discuss with your doctor. For each download of the sheet, ClevelandDx will donate to ZERO Prostate Cancer, with the nonprofit matching all donations in September. It’s a powerful way to support research and education! Download here: https://hubs.li/Q02Pl0gw0 Prostate cancer is the second most common and deadly cancer among American men, causing about 35,000 deaths annually. By starting conversations about screening at age 50 (or 40 for those at higher risk), we can make a significant difference in early detection and prevention. This year, Cleveland Diagnostics secured $75 million in funding to further their innovative IsoPSA test and explore new cancer diagnostics, reinforcing their commitment to fighting cancer. ?? https://hubs.li/Q02Plm3F0 #ProstateCancerAwareness #PSAonPSA #ClevelandDiagnostics #CancerResearch #HealthEducation #ZeroProstateCancer #InnovationInHealthcare

We are honored that Fierce Life Sciences and Fierce Healthcare have named Cleveland Clinic Innovations as one of 2024’s Fierce 50 honorees! What a wonderful way to celebrate more than two decades of innovation! ??The Fierce 50 showcases 50 individuals and companies driving advancements in medicine, fostering innovation, and shaping the future of biopharma and healthcare. Since its founding in 2000, Cleveland Clinic Innovations has made remarkable strides in medical technology, securing more than 2,500 patents and 840 licenses, and spinning out 105 startups. Led by Geoff Vince, PhD, Executive Director of Cleveland Clinic Innovations, our department employs a unique "team of teams" approach, integrating diverse expertise across engagement, assessment, product development, licensing, and new company formation. This collaborative model ensures exceptional handling of every stage of innovation, from idea to market. "One of the overriding values that we look at is, what effect is this going to have on the patients? Is this something that is really going to transform clinical care?", says Dr. Vince. Looking ahead, our team is expanding its focus to artificial intelligence, digital health, and global partnerships, exploring new avenues for improving hospital operations and patient care. Read the full article highlighting Cleveland Clinic Innovations here: https://hubs.li/Q02Pdd9g0 #HealthcareInnovation #MedTech #ClevelandClinic #Innovation #PatientCare #ClevelandClinicInnovation

Want a recording of our Innovation in Action: Revolutionizing Healthcare - Webinar covering "Small Molecule Therapeutics for Castration Resistant Prostate Cancer" from today? Sign up here under RSVP and you will receive a copy: https://lnkd.in/gf-A8Es3 This insightful webinar discusses cutting-edge development of new prostate cancer therapeutics. Dr. Shaun Stauffer and Dr. Nima Sharifi delve into the role of several novel enzymes in castration resistant prostate cancer and their identification as targets for small molecule inhibitors. The session covers the development of new drug candidates and how they might be applied to improve patient care.

Today at 1pm! Don't miss our first webinar, "Small Molecule Therapeutics for Castration Resistant Prostate Cancer"!? ??RSVP here: https://lnkd.in/gVB_itbi

Today is #RideDay for our incredible #VeloSano2024 team! Wishing all the riders a safe and fun day as they put in hard work for a good cause. Latin for “swift cure”, VeloSano connects the cancer community with Cleveland Clinic’s expanding global impact in research, innovation and care. This unique partnership ensures an accelerated path to finding cures by making good on the promise – that one hundred percent of every dollar raised for VeloSano initiatives will support transformative, lifesaving cancer research happening at Cleveland Clinic today, in order to impact the lives of millions of people around the world, tomorrow. https://lnkd.in/gjy7djWJ

?? Join us at Ohio VC Fest on September 17 & 18 at the Huntington Convention Center of Cleveland, a premier two-day event celebrating tech innovation and venture capital in Ohio. Connect with top investors, institutions, and entrepreneurs through curated meetings and networking sessions. JD Friedland, MBA, Managing Director, Ventures, will be joining a a dynamic panel on "Investment Strategy for Health Tech Startups." This interactive workshop will tackle real-world funding challenges and showcase diverse success stories from seasoned experts. ?? Find Us At: - Venture Connection Zone: Meet with Cleveland Clinic Innovations representatives for pre-approved meetings. - Demo Hall: Check out cutting-edge tech from Cleveland Clinic Innovations portfolio companies, MediView XR, Inc. and Centerline Biomedical. https://hubs.li/Q02NS9hj0 Connect with our team: JD Friedland, MBA Heather Callahan, PhD, JD, EMBA Chidinma Nwachukwu James Ellis, JD, MBA Gerald J. Wilmink, PhD, MBA #OhioVCFest #HealthTech #InvestmentStrategy #Networking #Innovation #OhioVCFest24 #IgniteInnovateImpact JumpStart Inc. JumpStart Ventures